We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USAP
2951
DELISTED
Universal Stainless & Alloy
USAP
$287K ﹤0.01%
17,650
NBN icon
2952
Northeast Bank
NBN
$1.06B
$285K ﹤0.01%
17,029
JNCE
2953
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$285K ﹤0.01%
84,418
+8,524
+11% +$39.8K
CALA
2954
DELISTED
Calithera Biosciences, Inc
CALA
$285K ﹤0.01%
3,541
+294
+9% +$29K
LVO icon
2955
LiveOne
LVO
$61M
$283K ﹤0.01%
+5,714
New +$222K
FFNW
2956
DELISTED
First Financial Northwest, Inc
FFNW
$283K ﹤0.01%
18,271
+704
+4% +$10.8K
ESQ icon
2957
Esquire Financial Holdings
ESQ
$1.12B
$282K ﹤0.01%
12,950
WATT icon
2958
Energous
WATT
$77.6M
$282K ﹤0.01%
81
MGI
2959
DELISTED
MoneyGram International, Inc. New
MGI
$282K ﹤0.01%
140,711
-30,377
-18% -$97.7K
BOC icon
2960
Boston Omaha
BOC
$428M
$281K ﹤0.01%
12,000
ORN icon
2961
Orion Group Holdings
ORN
$396M
$276K ﹤0.01%
64,249
AMPY icon
2962
Amplify Energy
AMPY
$161M
$274K ﹤0.01%
36,377
VSI
2963
DELISTED
Vitamin Shoppe Inc.
VSI
$274K ﹤0.01%
57,758
-1,196
-2% -$8.98K
HBIO icon
2964
Harvard Bioscience
HBIO
$27.5M
$270K ﹤0.01%
8,489
BH.A icon
2965
Biglari Holdings Class A
BH.A
$1.25B
$269K ﹤0.01%
457
STIM icon
2966
Neuronetics
STIM
$138M
$269K ﹤0.01%
13,890
GAIA icon
2967
Gaia
GAIA
$46.8M
$268K ﹤0.01%
25,800
GDP
2968
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$266K ﹤0.01%
19,669
VHI icon
2969
Valhi
VHI
$380M
$265K ﹤0.01%
11,438
-216
-2% -$5.42K
AGFS
2970
DELISTED
AgroFresh Solutions Inc
AGFS
$264K ﹤0.01%
69,500
PMBC
2971
DELISTED
Pacific Mercantile Bancorp
PMBC
$264K ﹤0.01%
36,839
+4,900
+15% +$39.3K
LEAF
2972
DELISTED
Leaf Group Ltd.
LEAF
$264K ﹤0.01%
38,420
PLSE icon
2973
Pulse Biosciences
PLSE
$2.43B
$263K ﹤0.01%
22,900
+3,000
+15% +$36.3K
IEA
2974
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$262K ﹤0.01%
31,920
-980
-3% -$8.98K
PEBK icon
2975
Peoples Bancorp of North Carolina
PEBK
$229M
$259K ﹤0.01%
10,577
+900
+9% +$24.7K

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.